ALXN
Alexion Pharmaceuticals
ALXN
ALXN
Delisted
ALXN was delisted on the 20th of July, 2021.
645 hedge funds and large institutions have $20.1B invested in Alexion Pharmaceuticals in 2019 Q3 according to their latest regulatory filings, with 92 funds opening new positions, 246 increasing their positions, 226 reducing their positions, and 80 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
28% less capital invested
Capital invested by funds: $27.9B → $20.1B (-$7.74B)
36% less call options, than puts
Call options by funds: $176M | Put options by funds: $275M
Holders
645
Holding in Top 10
16
Calls
$176M
Puts
$275M
Top Buyers
| 1 | +$166M | |
| 2 | +$160M | |
| 3 | +$142M | |
| 4 |
D.E. Shaw & Co
New York
|
+$134M |
| 5 |
Ninety One (UK)
London,
United Kingdom
|
+$133M |
Top Sellers
| 1 | -$683M | |
| 2 | -$587M | |
| 3 | -$237M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$216M |
| 5 |
1832 Asset Management
Toronto,
Ontario, Canada
|
-$112M |